Professor DeHui Zou : Progress and Considerations in CAR-T Therapy for Diffuse Large B-Cell Lymphoma | 2024 CSCO Hematology Academic Conference

Professor DeHui Zou : Progress and Considerations in CAR-T Therapy for Diffuse Large B-Cell Lymphoma | 2024 CSCO Hematology Academic Conference

2024.03.05
With unceasing exploration, the grand event took place as scheduled. From January 26 to 28, 2024, the "Chinese Society of Clinical Oncology (CSCO) Leukemia Committee, Lymphoma Committee, and Myeloma Committee Work Meeting and the 2024 CSCO Academic Conference on Hematology, Lymphoma, and Myeloma" was grandly held in the beautiful city of Haikou. Renowned experts and scholars from home and abroad gathered to share and exchange on the latest advancements and hot topics in the field of hematologic malignancies. At the conference, Professor DeHui Zou from the Lymphoma Diagnosis and Treatment Center of the Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, presented on "Progress and Considerations in CAR-T Therapy for B-Cell Lymphomas," sharing the latest research progress in the efficacy, therapeutic status, challenges faced, and optimization strategies for CAR-T treatment of Diffuse Large B-Cell Lymphoma (DLBCL). The following is a special summary.
ESMO Exclusive Interview | Professor Changsong Qi: CAR-T Therapy IM96 Shows Significant Antitumor Activity in Advanced Colorectal Cancer with GCC Expression

ESMO Exclusive Interview | Professor Changsong Qi: CAR-T Therapy IM96 Shows Significant Antitumor Activity in Advanced Colorectal Cancer with GCC Expression

2023.11.17
The 2023 European Society for Medical Oncology (ESMO) Annual Meeting took place in Madrid, Spain, from October 20th to 24th. The Oncology Frontier team delved into the frontline, capturing international advancements and witnessing the strides made by China in the global oncology arena. Professor Changsong Qi from Peking University Cancer Hospital delivered a crucial oral presentation (Abstract No: 1018O) at this conference. In an exclusive interview with Oncology Frontier, Professor Qi shared insights from his reported research and thoughts on colorectal cancer studies presented at this year's ESMO. This article compiles relevant content for readers.